| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Johnson & Johnson's insiders have reduced their positions by a net 236,286 shares worth roughly $62.0M.
JNJ sits in the Pharmaceuticals industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 276.0K | $72.03M | - | |
| VP | 194.5K | $51.21M | - | |
| VP | 114.3K | $27.56M | - | |
| VP | 25.7K | $6.24M | - | |
| VP | 25.4K | $3.85M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 17, 2025 | Reed John C | EVP, Innovative Medicine, R&D | Sell | 19,137 | $163.55 | $3,129,829.56 | -64.2% | +17.3% | - | |
| Feb 25, 2025 | Decker Robert J59 | VP Corporate Controller | Sale+OE | 6,999 | $165.88 | $1,160,994.12 | -25.0% | -7.7% | +47.6% | |
| Feb 18, 2025 | Schmid Timothy | EVP, Ww Chair, Medtech | Sale+OE | 403 | $156.15 | $62,928.45 | -2.6% | -1.6% | +58.1% | |
| Feb 7, 2025 | Wolk Joseph J | Executive VP, CFO | Sale+OE | 13,015 | $153.89 | $2,002,878.35 | - | +1.7% | +56.7% | |
| Dec 12, 2024 | Weinberger Mark A | Director | Buy | 1,000 | $147.22 | $147,220.00 | New | +11.4% | +44.7% | |
| Aug 30, 2024 | Decker Robert J59 | VP Corporate Controller | Sale+OE | 5,635 | $165.06 | $930,113.10 | -22.9% | -6.5% | +6.8% | |
| Mar 13, 2024 | Broadhurst Vanessa | EVP, Global Corp Affairs | Sell | 8,891 | $162.16 | $1,441,764.56 | -37.1% | -8.9% | +1.2% | |
| Feb 9, 2024 | Taubert Jennifer L50 | EVP, Ww Chair, Pharmaceuticals | Sale+OE | 59,397 | $156.27 | $9,281,969.19 | -29.6% | -4.4% | -2.3% | |
| Jul 26, 2023 | Hait William65 | See Remarks | Sale+OE | 14,698 | $172.00 | $2,528,056.00 | -14.3% | -12.4% | -7.6% | |
| Jul 25, 2023 | Fasolo Peter61 | Executive VP, Chief Hr Officer | Sell | 20,000 | $170.32 | $3,406,498.00 | -16.3% | -12.2% | -9.3% |